This conference is accredited by Ministry of Health, UAE for 10 CME credit points and by Council of Nursing and Nursing Specialization for Cooperation Council States by 10 CNE credit points.
Chairperson day 1:
Dr. Fatma H. AlMarashi, Medical Director, University Hospital - DHCC, UAE
Chairperson day 2:
Prof. Peter Schwarz, Head of The Division of Prevention and Care of Diabetes at the Department of Internal Medicine III, University of Dresden, Germany
Venue:
Movenpick Hotel Jumeirah Beach, Dubai, UAE
Download Booking form - click here
Download Visa Application Form - click here
Booking Forms and Visa Aplication Forms to be faxed to +971 4 449 8889 or e-mailed to Central Reservations on hotel.jumeirahbeach.reservation@moevenpick.com.
Event Summary:
Diabetes is a global threat, researchers estimate that 366 million people, or 4.4% of the world’s population will be diabetic by 2030. Diabetes prevalence in some countries in the ME Region is among the highest in the world. Studies conducted in different populations have reported prevalence rates as high as 20% in the United Arab Emirates, 16% in Qatar and 15% in Bahrain.
Former United Nations Secretary-General Kofi Annan underlined the need for global action: “Across the world, the threat [of diabetes] is ignored and under-funded. Tackling diabetes must be a priority. It is so serious that we all have to be involved if we are to reverse this epidemic.” The human and economic costs of this epidemic are enormous, diabetes increases the risk for heart disease and other health problems, and therefore it is important to give this disease more attention.
The purpose of this forum is to bring together international experts from International health organizations, national health authorities, local diabetic associations, academics, and local, regional and global media to:
- Highlight the rising prevalence of diabetes and its complications in the world in general and in the middle east in particular
- Discuss the recent issues related to prevention, management and treatment of diabetes.
- Develop global and national strategies to reduce the socio-economic burden of diabetes.
- Create a network of committed global and regional key opinion leaders to exchange their knowledge and experiences and by this way contribute to overall improvement of patient care.
As per the fabulous response towards the event, it is already confirmed that this highly successful event will follow up with its 2nd Annual series. The2nd Annual International Diabetes Summit will take place from 25th to 26th February 2011.
For speaking opportunities kindly contact: Doaa Said at
Doaa.said@fleminggulf.com
Key speakers:
- Prof. Peter Schwarz, Head of The Division of Prevention and Care of Diabetes at the Department of Internal Medicine III, University of Dresden, Germany
- Prof. Tawfik Ahmed Khoja, Executive Director, Executive Board of the health ministries
- Dr. Abdulrahman Salem Alkuwari, President, Gulf Group for the Study of Diabetes, Qatar
- Dr. Abdulaziz Al Twaim, Vice president and King Abdulaziz Medical City, Section Head and Consultant Pediatric Endocrinologist, Saudi Pediatric Association
- Dr. Nabil Naggar, Head of diabetes center, Hai Al Jamea Hospital, KSA
- Dr. Mariam E.A. Al Hajeri, Vice- President and Consultant Family Physician, Bahrain Diabetes Society, Bahrain
- Dr. Ibtihal Fadil, The Regional Office for The Eastern Mediterranean EMRO, Regional Advisor, World Health Organization (WHO)
- Dr. Mahmoud Fikri, CEO Health Policies Affairs and Chairman of National Diabetes Board, Ministry of Health UAE
- Dr. Belal Al Shammaa, Director, Consultant Endocrinologist, The American Hospital Dubai, Diabetes Center of Excellence, UAE
- Ahmed Omer Hawsawi, Representative, Council of Nursing and Nursing Specialization for Cooperation Council States
- Dr. Surendra Ugale, Chief & Director of Laparoscopic Training Institute, Advanced Laparoscopy & Metabolic Surgery Center, Kirloskar Hospital, India
- Dr. Fatma H. AlMarashi, Medical Director, University Hospital - DHCC, UAE
- Dr. med. Gerhard Klausmann, Diabetologist, Group practice, Germany
- Prof. David Owens, Diabetes Research Unit, Professor of Medicine, University Hospital Llandough, UK
Our valued advisors:
- Dr. Abdulrahman Salem Alkuwari, President, Chairman of the Advisory Council, Gulf Group for the Study of Diabetes, Qatar
- Dr. Hassan Mziaut, Senior Scientist, Solimena Group, Germany
- Dr. Mohammed Kamal Mostafa, Representative, The Egyptian Medical Association for the Study of Obesity (EMASO), Egypt
- Dr. Jason Halford, Professor at the dept. of Psychology, University of Liverpool, UK
- Dr. Abdulmoein Al Agha, Consultant Pediatric Endocrinologist, King Abdulaziz University Hospital, KSA
- Prof. Saverio Cinti, Professor, Faculty of medicine Ancona, Italy
- Dr. Nabil Naggar, Head of diabetes center, Hai Al Jamea Hospital, KSA
Key topics:
- Global Impact of Diabetes
- Diabetes in Middle East – Challenges and Opportunities
- National strategies to reduce the socio economic burden of diabetes
- Clinical Diabetes
- Diabetes and Cardiovascular Risk management
- Juvenile Diabetes
- Diabetes in Pregnancy
Who should attend:
Job Titles:
Heads and managers who are: Diabetologists, Psychologists, Endocrinologists, Internal medicine doctors, General practitioners, Healthcare professionals who manage the complications of patients with diabetes: e.g. Ophthalmologists, cardiologists, Podiatrics..... etc; Chief nurses, Chief pharmacists etc.
from Local Diabetic Associations; National Health Authorities; Hospital and medical clinics
Industries:
Diabetic care devices providers, Pharmaceutical companies providing Insulin and oral diabetic medicines, Bariatric Surgery providers etc.
Brochure Request
| Event info: T: +9181 0580 5411 F: +9180 4050 9933 E: lucia.kasanicka@fleminggulf.com |
Sponsorship info: T: +9197 3118 3803 F: +9180 4050 9933 E: john.paul@fleminggulf.com |
Sponsors
Platinum Sponsor:
Sanofi-aventis’ ambition is to become a diversified global healthcare leader, Focused on patients’ needs. The Group strategy is based on three key principles in order to deliver long-term sustainable growth: A) Increasing innovation in Research & Development; B) Seizing external growth opportunities; C) Adapting Group structures for future challenges.
Gold Sponsors:
Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions. We are committed to providing answers that matter - through medicines and information - for some of the world's most urgent medical needs. We employ more than 44,000 people worldwide and market our medicines in 143 countries. Lilly has major research and development facilities in nine countries, with over 8,400 employees carrying out clinical research in more than 60 countries.
BD – Diabetes Care: Our products are mainly devices of Insulin injection (Pen needles, Syringes) and capillary sampling (Lancets and lancer devices). We are strongly involved towards diabetic patients and health care professionals in order to: Offer best comfort to all patients through the compatibility and other technical features of our products as concerns with BD micro Fine + technology; Support health care professionals and patients by developing educational programs and training sessions to share with them the latest studies that enhance the accurate injection technique; Develop a data base for the Injection technique in the Middle East in order to enhance the level of performance and meet the educational and technical needs to serve the patients need. Our Vision is: Great performance; Great contribution to society & Great place to work.
Associate Sponsor:
Exhibitors:
Western Healthcare Technology was founded in 2009 covering the United Arab Emirates representing ACON Diabetes Care, a Global leader in Blood Glucose Monitoring System. Creating awareness among the people and providing information to better manage Diabetes, with a highly competitive price and quality maintained products, it would be more convenient for valued customers who believe only in quality. The partnership aims to be the global leader in our industry based on consistent quality and execution, exceptional customer aligned services and constant innovation. We look forward in achieving our objectives and prime dream to be of service to the community by giving the most affordable quality service and supplies.
Project winner of the French National Award for innovating company creation, OTR3 was created in 2000 by Professors Jean-Pierre Caruelle and Denis Barritault. OTR3, for Organ, Tissue, Regeneration, Reparation, Replacement, conceives and develops active therapeutic agents, especially RGTA (ReGeneraTing Agent), and ensure their market availability. The aim is to bring new therapeutic solutions to the healthcare professionals, and comfort to the patients by promoting the research on the extracellular matrix and develop healing care products.
GSMS provides every health care facility in the region with the most advanced medical technology available globally making it accessible to the end user in need; direct its growth in the areas of medical engineering where we exhibit maximum strength and capability; to gather people and facilities that tend to enhance these areas and focus on sustain good citizenship as a corporation.
Strategic Partner:
Supporting Associations:
Council of Nursing and Nursing Specialization for Cooperation Council States
Media Partners:
Pharma Voice Free Digital Subscription:
